Breaking News

CPhI North America Reschedules Event

To take place September 9-11, 2020 in Philadelphia, PA

CPhI North America Reschedules Event

03.12.20

Due to developments concerning the coronavirus, CPhI North America 2020 has been rescheduled and will take place September 9-11, 2020 in Philadelphia, PA at the Pennsylvania Convention Center. The meeting was originally scheduled for May 5-7, 2020.

CPhI North America is dedicated to pharmaceutical and biopharmaceutical drug development and manufacturing. The event features sessions addressing the latest industry topics on Drug Development, Drug Manufacturing, and Bioprocessing, and provides the opportunity for industry buyers to connect with industry-leading suppliers of contract services.

Related Searches

Related Breaking News

Breaking News | Industry News | Promotions & Moves

Benuvia Manufacturing Appoints K. Scott Aladeen as Chief Operating Officer

Aladeen has four decades of pharmaceutical experience.
10.27.21
Bio News | Breaking News | Facilities | Industry News

Bionova Scientific Opens Biologics Manufacturing Facility

Unveils commercial-ready GMP biologics manufacturing facility at grand opening event attended by clients, vendors, industry leaders and government officials.
10.27.21
Breaking News | Industry News | Promotions & Moves

Exothera Appoints Hanna Lesch as Chief Technology Officer

Lesch has dedicated her career to gene therapy and has held several director positions.
10.27.21
Bio News | Breaking News | Clinical Trial Materials | Collaborations & Alliances | Industry News

Fujifilm Diosynth Biotechnologies, Istari Oncology Enter Manufacturing Agreement

To advance its viral immunotherapy PVSRIPO.
10.27.21
Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News

Jaguar Gene Therapy Announces Plans for New Commercial Manufacturing Facility in NC

The 174,000-square-foot facility will support future clinical and commercial production of the company’s initial programs.
10.27.21
Breaking News | Industry News

CPhI Annual Report Predicts the Pharma Environment in 2030

Releases new findings ahead of CPhI Worldwide, which is being held for the first time in two years at the Fiera Milan, Italy.
10.27.21
APIs | Breaking News | Collaborations & Alliances | Industry News

Phlow Included in BARDA CDMO Network

Will provide domestic API capability for essential medicines and medical countermeasures.
10.27.21
Breaking News | Collaborations & Alliances | Industry News

Recro Becomes Commercial Supplier for Otsuka

The CDMO enters master commercial supply and services agreement with the Japanese pharma major.
10.27.21
Bio News | Bioanalytical Services | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News | Process Development

Waters and Sartorius Enter Bioprocessing Partnership

Collaboration to help bioprocess scientists accelerate clone selection and process development.
10.27.21
Breaking News | Industry News | Promotions & Moves

Abzena Promotes Dr. Louise Duffy as Chief Technical Officer

Duffy has more than 30 years’ experience in the industry.
10.27.21
Breaking News | Collaborations & Alliances

Rentschler Biopharma, XL-Protein Enter Manufacturing Pact

Will manufacture a long-acting, hyperactive recombinant human deoxyribonuclease I.
10.26.21
Collaborations & Alliances | Drug Development

Secarna, Denali Therapeutics Expand Strategic CNS Pact

To broaden use of Secarna's ASO discovery and development platform LNAplus and Denali's blood-brain barrier Transport Vehicle technology.
10.26.21
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News

BioNTech to Build mRNA Vaccine Mfg. Facility in Africa

The first mRNA manufacturing facility in Africa will enable an annual manufacturing capacity of several hundreds of million mRNA vaccine doses.
10.26.21
Collaborations & Alliances | Drug Delivery

Aptar Pharma Enters Exclusive Partnership with Stallergenes Greer

Will develop a novel digital health ecosystem for allergen immunotherapy treatment.
10.26.21
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News

Catalent Invests $230M in Harmans Gene Therapy Campus

Will house 18 CGMP viral vector manufacturing suites designed to accommodate multiple bioreactors up to 2,000-liter scale and commercial manufacturing.
10.26.21